tirzepatide 2023 FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly EASD 2023: meta-analysis shows tirzepatide

The FDA has issued multiple warning letters to Empower over the past several years, documenting concerns about sterile compounding practices, contamination control, and quality assurance procedures

I asked questions of my assigned doctor as well as my coach. If ease and affordability are your top priorities, Hers is the most frictionless GLP-1 option on the market

By Traci Watson 0 Traci Watson Traci Watson a senior editor for news and research highlights at Nature

When it comes to determining the correct dosage of a peptide, a calculator or chart can be utilized to accurately measure out the required amount of bacteriostatic water to add

The extra weeks invested in microdosing translate into a smoother experience at therapeutic doses, better adherence to the protocol long-term, and potentially better outcomes